Skip to main content
Amod Sarnaik, MD, General Surgery, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

AmodSarnaikMD

General Surgery Tampa, FL

Melanoma, Surgical Oncology (Other than Breast)

Physician

Overview of Dr. Sarnaik

Dr. Amod Sarnaik is a general surgeon in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and James A. Haley Veterans' Hospital-Tampa. He received his medical degree from University of Michigan Medical School and has been in practice 18 years. Dr. Sarnaik accepts several types of health insurance, listed below. He is one of 84 doctors at H. Lee Moffitt Cancer Center and Research Institute and one of 39 doctors at James A. Haley Veterans' Hospital-Tampa who specialize in General Surgery. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Cincinnati Medical Center/College of Medicine
    University of Cincinnati Medical Center/College of MedicineResidency, Surgery, 1999 - 2006
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2007 - 2026
  • OH State Medical License
    OH State Medical License 1999 - 2006
  • American Board of Surgery Surgery

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?  
    C Wayne Cruse, Vernon K Sondak, Ricardo J Gonzalez, Daniel E Oliver, Jane L Messina, Louis B Harrison, Jonathan S Zager, Amod A Sarnaik, Annals of Surgical Oncology
  • Talimogene Laherparepvec (TVEC) for the Treatment of Advanced Melanoma: A Single-Institution Experience  
    Jonathan S Zager, Amod A Sarnaik, Annals of Surgical Oncology
  • Resection Margins in Merkel Cell Carcinoma: Is a 1-Cm Margin Wide Enough?  
    Daniel E Oliver, Vernon K Sondak, C Wayne Cruse, Louis B Harrison, Ricardo J Gonzalez, Amod A Sarnaik, Jonathan S Zager, Jane L Messina, Annals of Surgical Oncology

Lectures

  • Safety and efficacy of cryopreserved autologous tumor infiltrating lymphocyte therapy (LN-144, lifileucel) in advanced metastatic melanoma patients who progressed on m... 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

  • Moffitt Cancer Center on Cutting Edge of New Treatment That Could Save Lives of Advanced Melanoma Patients
    Moffitt Cancer Center on Cutting Edge of New Treatment That Could Save Lives of Advanced Melanoma PatientsNovember 22nd, 2022
  • Combo T Cell and Targeted Therapy Strategy for Resistant Melanoma with BRAF Mutation
    Combo T Cell and Targeted Therapy Strategy for Resistant Melanoma with BRAF MutationFebruary 18th, 2019
  • Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
    Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer’s 33rd Annual MeetingNovember 6th, 2018
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Aetna Whole Health Banner Health Network
    AvMed Health Open Access
    BCBS Arizona BlueAlliance Network
    BCBS Blue Card PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Florida - Employer Group PPO
    First Health PPO
    Great West PPO
    Health Net Arizona HMO
    Health Net Arizona HMO ExcelCare Network
    Health Net Arizona PPO/POS
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment